nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—ADRA2A—type 2 diabetes mellitus	0.45	1	CbGaD
Propericiazine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.134	0.406	CbGbCtD
Propericiazine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.108	0.326	CbGbCtD
Propericiazine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0885	0.268	CbGbCtD
Propericiazine—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000327	0.00216	CcSEcCtD
Propericiazine—Rash—Tolazamide—type 2 diabetes mellitus	0.000327	0.00216	CcSEcCtD
Propericiazine—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.000326	0.00216	CcSEcCtD
Propericiazine—Agitation—Bromocriptine—type 2 diabetes mellitus	0.000326	0.00215	CcSEcCtD
Propericiazine—Confusional state—Glimepiride—type 2 diabetes mellitus	0.000323	0.00214	CcSEcCtD
Propericiazine—Rash—Linagliptin—type 2 diabetes mellitus	0.000323	0.00214	CcSEcCtD
Propericiazine—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000323	0.00213	CcSEcCtD
Propericiazine—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.000318	0.0021	CcSEcCtD
Propericiazine—Infection—Sitagliptin—type 2 diabetes mellitus	0.000318	0.0021	CcSEcCtD
Propericiazine—Vomiting—Acarbose—type 2 diabetes mellitus	0.000316	0.00209	CcSEcCtD
Propericiazine—Rash—Acarbose—type 2 diabetes mellitus	0.000314	0.00207	CcSEcCtD
Propericiazine—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000314	0.00207	CcSEcCtD
Propericiazine—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000313	0.00207	CcSEcCtD
Propericiazine—Drowsiness—Metformin—type 2 diabetes mellitus	0.000312	0.00206	CcSEcCtD
Propericiazine—Insomnia—Glipizide—type 2 diabetes mellitus	0.000311	0.00205	CcSEcCtD
Propericiazine—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.00031	0.00205	CcSEcCtD
Propericiazine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000308	0.00203	CcSEcCtD
Propericiazine—Nausea—Tolazamide—type 2 diabetes mellitus	0.000308	0.00203	CcSEcCtD
Propericiazine—Eosinophilia—Losartan—type 2 diabetes mellitus	0.000307	0.00203	CcSEcCtD
Propericiazine—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000306	0.00202	CcSEcCtD
Propericiazine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000306	0.00202	CcSEcCtD
Propericiazine—Somnolence—Glipizide—type 2 diabetes mellitus	0.000306	0.00202	CcSEcCtD
Propericiazine—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000305	0.00202	CcSEcCtD
Propericiazine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000305	0.00202	CcSEcCtD
Propericiazine—Tremor—Glyburide—type 2 diabetes mellitus	0.000304	0.00201	CcSEcCtD
Propericiazine—Rash—Nateglinide—type 2 diabetes mellitus	0.000303	0.002	CcSEcCtD
Propericiazine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000302	0.002	CcSEcCtD
Propericiazine—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	0.000301	0.00199	CcSEcCtD
Propericiazine—Weight increased—Irbesartan—type 2 diabetes mellitus	0.0003	0.00198	CcSEcCtD
Propericiazine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.0003	0.00198	CcSEcCtD
Propericiazine—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000299	0.00197	CcSEcCtD
Propericiazine—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000298	0.00197	CcSEcCtD
Propericiazine—Hyperglycaemia—Irbesartan—type 2 diabetes mellitus	0.000297	0.00197	CcSEcCtD
Propericiazine—Angioedema—Glyburide—type 2 diabetes mellitus	0.000296	0.00196	CcSEcCtD
Propericiazine—Pneumonia—Irbesartan—type 2 diabetes mellitus	0.000296	0.00195	CcSEcCtD
Propericiazine—Nausea—Acarbose—type 2 diabetes mellitus	0.000296	0.00195	CcSEcCtD
Propericiazine—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000295	0.00195	CcSEcCtD
Propericiazine—Constipation—Glipizide—type 2 diabetes mellitus	0.000294	0.00194	CcSEcCtD
Propericiazine—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000294	0.00194	CcSEcCtD
Propericiazine—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.000292	0.00193	CcSEcCtD
Propericiazine—Insomnia—Glimepiride—type 2 diabetes mellitus	0.00029	0.00192	CcSEcCtD
Propericiazine—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000289	0.00191	CcSEcCtD
Propericiazine—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000289	0.00191	CcSEcCtD
Propericiazine—Infection—Bromocriptine—type 2 diabetes mellitus	0.000287	0.0019	CcSEcCtD
Propericiazine—Jaundice—Irbesartan—type 2 diabetes mellitus	0.000287	0.00189	CcSEcCtD
Propericiazine—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000286	0.00189	CcSEcCtD
Propericiazine—Erectile dysfunction—Losartan—type 2 diabetes mellitus	0.000286	0.00189	CcSEcCtD
Propericiazine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000285	0.00188	CcSEcCtD
Propericiazine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000285	0.00188	CcSEcCtD
Propericiazine—Cardiac disorder—Valsartan—type 2 diabetes mellitus	0.000285	0.00188	CcSEcCtD
Propericiazine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000284	0.00188	CcSEcCtD
Propericiazine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000284	0.00188	CcSEcCtD
Propericiazine—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000283	0.00187	CcSEcCtD
Propericiazine—Weight increased—Losartan—type 2 diabetes mellitus	0.000282	0.00187	CcSEcCtD
Propericiazine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000282	0.00187	CcSEcCtD
Propericiazine—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.00028	0.00185	CcSEcCtD
Propericiazine—Pneumonia—Losartan—type 2 diabetes mellitus	0.000278	0.00184	CcSEcCtD
Propericiazine—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000274	0.00181	CcSEcCtD
Propericiazine—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000273	0.00181	CcSEcCtD
Propericiazine—Tremor—Gliclazide—type 2 diabetes mellitus	0.000273	0.0018	CcSEcCtD
Propericiazine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00027	0.00179	CcSEcCtD
Propericiazine—Jaundice—Losartan—type 2 diabetes mellitus	0.00027	0.00178	CcSEcCtD
Propericiazine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000269	0.00178	CcSEcCtD
Propericiazine—Agitation—Gliclazide—type 2 diabetes mellitus	0.000267	0.00177	CcSEcCtD
Propericiazine—Confusional state—Glyburide—type 2 diabetes mellitus	0.000267	0.00176	CcSEcCtD
Propericiazine—Asthma—Ramipril—type 2 diabetes mellitus	0.000266	0.00176	CcSEcCtD
Propericiazine—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000266	0.00176	CcSEcCtD
Propericiazine—Oedema—Glyburide—type 2 diabetes mellitus	0.000265	0.00175	CcSEcCtD
Propericiazine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000264	0.00175	CcSEcCtD
Propericiazine—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000263	0.00174	CcSEcCtD
Propericiazine—Rash—Repaglinide—type 2 diabetes mellitus	0.000262	0.00173	CcSEcCtD
Propericiazine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000262	0.00173	CcSEcCtD
Propericiazine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000262	0.00173	CcSEcCtD
Propericiazine—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.00026	0.00172	CcSEcCtD
Propericiazine—Sweating increased—Ramipril—type 2 diabetes mellitus	0.000259	0.00171	CcSEcCtD
Propericiazine—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000258	0.00171	CcSEcCtD
Propericiazine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000258	0.0017	CcSEcCtD
Propericiazine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000257	0.0017	CcSEcCtD
Propericiazine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000256	0.00169	CcSEcCtD
Propericiazine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000253	0.00167	CcSEcCtD
Propericiazine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000252	0.00167	CcSEcCtD
Propericiazine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000249	0.00165	CcSEcCtD
Propericiazine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000248	0.00164	CcSEcCtD
Propericiazine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000247	0.00163	CcSEcCtD
Propericiazine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000247	0.00163	CcSEcCtD
Propericiazine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000247	0.00163	CcSEcCtD
Propericiazine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000247	0.00163	CcSEcCtD
Propericiazine—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000245	0.00162	CcSEcCtD
Propericiazine—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000245	0.00162	CcSEcCtD
Propericiazine—Angioedema—Valsartan—type 2 diabetes mellitus	0.000244	0.00161	CcSEcCtD
Propericiazine—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000243	0.00161	CcSEcCtD
Propericiazine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000243	0.0016	CcSEcCtD
Propericiazine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000242	0.0016	CcSEcCtD
Propericiazine—Weight increased—Ramipril—type 2 diabetes mellitus	0.000242	0.0016	CcSEcCtD
Propericiazine—Angioedema—Orlistat—type 2 diabetes mellitus	0.000241	0.0016	CcSEcCtD
Propericiazine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000239	0.00158	CcSEcCtD
Propericiazine—Fluphenazine—CALM1—type 2 diabetes mellitus	0.000238	0.0463	CrCbGaD
Propericiazine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000236	0.00156	CcSEcCtD
Propericiazine—Infection—Gliclazide—type 2 diabetes mellitus	0.000236	0.00156	CcSEcCtD
Propericiazine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000236	0.00156	CcSEcCtD
Propericiazine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000236	0.00156	CcSEcCtD
Propericiazine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000236	0.00156	CcSEcCtD
Propericiazine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000235	0.00155	CcSEcCtD
Propericiazine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000233	0.00154	CcSEcCtD
Propericiazine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000232	0.00153	CcSEcCtD
Propericiazine—Jaundice—Ramipril—type 2 diabetes mellitus	0.000231	0.00153	CcSEcCtD
Propericiazine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00023	0.00152	CcSEcCtD
Propericiazine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000229	0.00152	CcSEcCtD
Propericiazine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000229	0.00151	CcSEcCtD
Propericiazine—Tremor—Metformin—type 2 diabetes mellitus	0.000228	0.00151	CcSEcCtD
Propericiazine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000225	0.00149	CcSEcCtD
Propericiazine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000223	0.00147	CcSEcCtD
Propericiazine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000222	0.00147	CcSEcCtD
Propericiazine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000222	0.00147	CcSEcCtD
Propericiazine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000221	0.00146	CcSEcCtD
Propericiazine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00022	0.00145	CcSEcCtD
Propericiazine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000219	0.00145	CcSEcCtD
Propericiazine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000219	0.00145	CcSEcCtD
Propericiazine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000219	0.00144	CcSEcCtD
Propericiazine—Oedema—Valsartan—type 2 diabetes mellitus	0.000218	0.00144	CcSEcCtD
Propericiazine—Infection—Valsartan—type 2 diabetes mellitus	0.000217	0.00143	CcSEcCtD
Propericiazine—Rash—Glipizide—type 2 diabetes mellitus	0.000217	0.00143	CcSEcCtD
Propericiazine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000217	0.00143	CcSEcCtD
Propericiazine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000217	0.00143	CcSEcCtD
Propericiazine—Oedema—Orlistat—type 2 diabetes mellitus	0.000216	0.00142	CcSEcCtD
Propericiazine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000215	0.00142	CcSEcCtD
Propericiazine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000215	0.00142	CcSEcCtD
Propericiazine—Infection—Orlistat—type 2 diabetes mellitus	0.000214	0.00142	CcSEcCtD
Propericiazine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000212	0.0014	CcSEcCtD
Propericiazine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000211	0.0014	CcSEcCtD
Propericiazine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000211	0.0014	CcSEcCtD
Propericiazine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00021	0.00139	CcSEcCtD
Propericiazine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000208	0.00138	CcSEcCtD
Propericiazine—Nausea—Glipizide—type 2 diabetes mellitus	0.000204	0.00135	CcSEcCtD
Propericiazine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000204	0.00135	CcSEcCtD
Propericiazine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000204	0.00135	CcSEcCtD
Propericiazine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000204	0.00135	CcSEcCtD
Propericiazine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000203	0.00134	CcSEcCtD
Propericiazine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000203	0.00134	CcSEcCtD
Propericiazine—Tremor—Losartan—type 2 diabetes mellitus	0.000203	0.00134	CcSEcCtD
Propericiazine—Rash—Glimepiride—type 2 diabetes mellitus	0.000202	0.00134	CcSEcCtD
Propericiazine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000202	0.00134	CcSEcCtD
Propericiazine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000202	0.00133	CcSEcCtD
Propericiazine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000201	0.00133	CcSEcCtD
Propericiazine—Agitation—Losartan—type 2 diabetes mellitus	0.000199	0.00131	CcSEcCtD
Propericiazine—Oedema—Metformin—type 2 diabetes mellitus	0.000199	0.00131	CcSEcCtD
Propericiazine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000198	0.00131	CcSEcCtD
Propericiazine—Angioedema—Losartan—type 2 diabetes mellitus	0.000198	0.00131	CcSEcCtD
Propericiazine—Infection—Metformin—type 2 diabetes mellitus	0.000197	0.0013	CcSEcCtD
Propericiazine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000197	0.0013	CcSEcCtD
Propericiazine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000195	0.00129	CcSEcCtD
Propericiazine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000195	0.00129	CcSEcCtD
Propericiazine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000195	0.00129	CcSEcCtD
Propericiazine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000194	0.00128	CcSEcCtD
Propericiazine—Promethazine—CALM1—type 2 diabetes mellitus	0.000193	0.0375	CrCbGaD
Propericiazine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000192	0.00127	CcSEcCtD
Propericiazine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000191	0.00126	CcSEcCtD
Propericiazine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000191	0.00126	CcSEcCtD
Propericiazine—Trifluoperazine—CALM1—type 2 diabetes mellitus	0.00019	0.037	CrCbGaD
Propericiazine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.00019	0.00126	CcSEcCtD
Propericiazine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00019	0.00125	CcSEcCtD
Propericiazine—Perphenazine—CALM1—type 2 diabetes mellitus	0.000188	0.0366	CrCbGaD
Propericiazine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000188	0.00124	CcSEcCtD
Propericiazine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000188	0.00124	CcSEcCtD
Propericiazine—Constipation—Valsartan—type 2 diabetes mellitus	0.000187	0.00123	CcSEcCtD
Propericiazine—Infection—Irbesartan—type 2 diabetes mellitus	0.000186	0.00123	CcSEcCtD
Propericiazine—Cyamemazine—HTR2C—type 2 diabetes mellitus	0.000186	0.0361	CrCbGaD
Propericiazine—Hypotension—Metformin—type 2 diabetes mellitus	0.000186	0.00123	CcSEcCtD
Propericiazine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000184	0.00122	CcSEcCtD
Propericiazine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000183	0.00121	CcSEcCtD
Propericiazine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000182	0.00121	CcSEcCtD
Propericiazine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000182	0.0012	CcSEcCtD
Propericiazine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000181	0.0012	CcSEcCtD
Propericiazine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000181	0.0012	CcSEcCtD
Propericiazine—Dry mouth—Losartan—type 2 diabetes mellitus	0.00018	0.00119	CcSEcCtD
Propericiazine—Confusional state—Losartan—type 2 diabetes mellitus	0.000178	0.00118	CcSEcCtD
Propericiazine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000177	0.00117	CcSEcCtD
Propericiazine—Somnolence—Metformin—type 2 diabetes mellitus	0.000177	0.00117	CcSEcCtD
Propericiazine—Oedema—Losartan—type 2 diabetes mellitus	0.000176	0.00117	CcSEcCtD
Propericiazine—Infection—Losartan—type 2 diabetes mellitus	0.000175	0.00116	CcSEcCtD
Propericiazine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000175	0.00116	CcSEcCtD
Propericiazine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000175	0.00116	CcSEcCtD
Propericiazine—Tremor—Ramipril—type 2 diabetes mellitus	0.000174	0.00115	CcSEcCtD
Propericiazine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000172	0.00114	CcSEcCtD
Propericiazine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000172	0.00114	CcSEcCtD
Propericiazine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000171	0.00113	CcSEcCtD
Propericiazine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00017	0.00113	CcSEcCtD
Propericiazine—Agitation—Ramipril—type 2 diabetes mellitus	0.00017	0.00113	CcSEcCtD
Propericiazine—Constipation—Metformin—type 2 diabetes mellitus	0.00017	0.00112	CcSEcCtD
Propericiazine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000169	0.00112	CcSEcCtD
Propericiazine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000168	0.00111	CcSEcCtD
Propericiazine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000167	0.0011	CcSEcCtD
Propericiazine—Rash—Glyburide—type 2 diabetes mellitus	0.000167	0.0011	CcSEcCtD
Propericiazine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000167	0.0011	CcSEcCtD
Propericiazine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000167	0.0011	CcSEcCtD
Propericiazine—Hypotension—Losartan—type 2 diabetes mellitus	0.000165	0.00109	CcSEcCtD
Propericiazine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000163	0.00107	CcSEcCtD
Propericiazine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000161	0.00106	CcSEcCtD
Propericiazine—Constipation—Irbesartan—type 2 diabetes mellitus	0.00016	0.00106	CcSEcCtD
Propericiazine—Insomnia—Losartan—type 2 diabetes mellitus	0.00016	0.00105	CcSEcCtD
Propericiazine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000159	0.00105	CcSEcCtD
Propericiazine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000157	0.00104	CcSEcCtD
Propericiazine—Nausea—Glyburide—type 2 diabetes mellitus	0.000157	0.00104	CcSEcCtD
Propericiazine—Somnolence—Losartan—type 2 diabetes mellitus	0.000157	0.00104	CcSEcCtD
Propericiazine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000154	0.00102	CcSEcCtD
Propericiazine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000153	0.00101	CcSEcCtD
Propericiazine—Oedema—Ramipril—type 2 diabetes mellitus	0.000151	0.001	CcSEcCtD
Propericiazine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000151	0.000998	CcSEcCtD
Propericiazine—Constipation—Losartan—type 2 diabetes mellitus	0.000151	0.000997	CcSEcCtD
Propericiazine—Rash—Gliclazide—type 2 diabetes mellitus	0.00015	0.00099	CcSEcCtD
Propericiazine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00015	0.000989	CcSEcCtD
Propericiazine—Chlorpromazine—CALM1—type 2 diabetes mellitus	0.000149	0.029	CrCbGaD
Propericiazine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000149	0.000987	CcSEcCtD
Propericiazine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000148	0.00098	CcSEcCtD
Propericiazine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000148	0.000976	CcSEcCtD
Propericiazine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000148	0.000975	CcSEcCtD
Propericiazine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000146	0.000967	CcSEcCtD
Propericiazine—Zuclopenthixol—ADRA2A—type 2 diabetes mellitus	0.000145	0.0281	CrCbGaD
Propericiazine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000141	0.000934	CcSEcCtD
Propericiazine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000141	0.000932	CcSEcCtD
Propericiazine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00014	0.000922	CcSEcCtD
Propericiazine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000139	0.000917	CcSEcCtD
Propericiazine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000138	0.000913	CcSEcCtD
Propericiazine—Rash—Valsartan—type 2 diabetes mellitus	0.000138	0.000909	CcSEcCtD
Propericiazine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000137	0.000908	CcSEcCtD
Propericiazine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000137	0.000906	CcSEcCtD
Propericiazine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000137	0.000904	CcSEcCtD
Propericiazine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000136	0.000898	CcSEcCtD
Propericiazine—Rash—Orlistat—type 2 diabetes mellitus	0.000136	0.000898	CcSEcCtD
Propericiazine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000136	0.000898	CcSEcCtD
Propericiazine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000135	0.000891	CcSEcCtD
Propericiazine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000135	0.000889	CcSEcCtD
Propericiazine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00013	0.000859	CcSEcCtD
Propericiazine—Nausea—Valsartan—type 2 diabetes mellitus	0.00013	0.000856	CcSEcCtD
Propericiazine—Constipation—Ramipril—type 2 diabetes mellitus	0.000129	0.000855	CcSEcCtD
Propericiazine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000128	0.000848	CcSEcCtD
Propericiazine—Nausea—Orlistat—type 2 diabetes mellitus	0.000128	0.000846	CcSEcCtD
Propericiazine—Vomiting—Metformin—type 2 diabetes mellitus	0.000126	0.000835	CcSEcCtD
Propericiazine—Rash—Metformin—type 2 diabetes mellitus	0.000125	0.000828	CcSEcCtD
Propericiazine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000125	0.000827	CcSEcCtD
Propericiazine—Thiothixene—ADRA2A—type 2 diabetes mellitus	0.000125	0.0242	CrCbGaD
Propericiazine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000121	0.000798	CcSEcCtD
Propericiazine—Domperidone—CYP1A2—type 2 diabetes mellitus	0.00012	0.0234	CrCbGaD
Propericiazine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00012	0.00079	CcSEcCtD
Propericiazine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000119	0.000788	CcSEcCtD
Propericiazine—Rash—Irbesartan—type 2 diabetes mellitus	0.000118	0.000781	CcSEcCtD
Propericiazine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000118	0.000781	CcSEcCtD
Propericiazine—Nausea—Metformin—type 2 diabetes mellitus	0.000118	0.00078	CcSEcCtD
Propericiazine—Thiothixene—HTR2C—type 2 diabetes mellitus	0.000115	0.0223	CrCbGaD
Propericiazine—Mesoridazine—HTR2C—type 2 diabetes mellitus	0.000113	0.022	CrCbGaD
Propericiazine—Vomiting—Losartan—type 2 diabetes mellitus	0.000112	0.000741	CcSEcCtD
Propericiazine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000111	0.000737	CcSEcCtD
Propericiazine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000111	0.000736	CcSEcCtD
Propericiazine—Rash—Losartan—type 2 diabetes mellitus	0.000111	0.000735	CcSEcCtD
Propericiazine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000111	0.000735	CcSEcCtD
Propericiazine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	0.00011	0.0213	CrCbGaD
Propericiazine—Fluphenazine—ADRA2A—type 2 diabetes mellitus	0.000108	0.021	CrCbGaD
Propericiazine—Nausea—Losartan—type 2 diabetes mellitus	0.000105	0.000693	CcSEcCtD
Propericiazine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000104	0.000684	CcSEcCtD
Propericiazine—Fluphenazine—HTR2C—type 2 diabetes mellitus	9.92e-05	0.0193	CrCbGaD
Propericiazine—Clomipramine—ADRA2A—type 2 diabetes mellitus	9.85e-05	0.0192	CrCbGaD
Propericiazine—Vomiting—Ramipril—type 2 diabetes mellitus	9.62e-05	0.000636	CcSEcCtD
Propericiazine—Propiomazine—HTR2C—type 2 diabetes mellitus	9.54e-05	0.0186	CrCbGaD
Propericiazine—Rash—Ramipril—type 2 diabetes mellitus	9.54e-05	0.00063	CcSEcCtD
Propericiazine—Dermatitis—Ramipril—type 2 diabetes mellitus	9.53e-05	0.00063	CcSEcCtD
Propericiazine—Alimemazine—CYP3A4—type 2 diabetes mellitus	9.36e-05	0.0182	CrCbGaD
Propericiazine—Thioridazine—ADRA2A—type 2 diabetes mellitus	9.28e-05	0.0181	CrCbGaD
Propericiazine—Clomipramine—HTR2C—type 2 diabetes mellitus	9.07e-05	0.0176	CrCbGaD
Propericiazine—Nausea—Ramipril—type 2 diabetes mellitus	8.99e-05	0.000594	CcSEcCtD
Propericiazine—Methotrimeprazine—ADRA2A—type 2 diabetes mellitus	8.86e-05	0.0172	CrCbGaD
Propericiazine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	8.66e-05	0.0168	CrCbGaD
Propericiazine—Thiothixene—CYP1A2—type 2 diabetes mellitus	8.66e-05	0.0168	CrCbGaD
Propericiazine—Thioridazine—HTR2C—type 2 diabetes mellitus	8.55e-05	0.0166	CrCbGaD
Propericiazine—Perphenazine—ADRA2A—type 2 diabetes mellitus	8.52e-05	0.0166	CrCbGaD
Propericiazine—Quetiapine—ADRA2A—type 2 diabetes mellitus	8.35e-05	0.0163	CrCbGaD
Propericiazine—Methotrimeprazine—HTR2C—type 2 diabetes mellitus	8.16e-05	0.0159	CrCbGaD
Propericiazine—Mequitazine—CYP3A4—type 2 diabetes mellitus	8.06e-05	0.0157	CrCbGaD
Propericiazine—Domperidone—CYP3A4—type 2 diabetes mellitus	7.96e-05	0.0155	CrCbGaD
Propericiazine—Trifluoperazine—HTR2C—type 2 diabetes mellitus	7.93e-05	0.0154	CrCbGaD
Propericiazine—Fluphenazine—CYP2E1—type 2 diabetes mellitus	7.87e-05	0.0153	CrCbGaD
Propericiazine—Perphenazine—HTR2C—type 2 diabetes mellitus	7.84e-05	0.0153	CrCbGaD
Propericiazine—Quetiapine—HTR2C—type 2 diabetes mellitus	7.69e-05	0.015	CrCbGaD
Propericiazine—Promazine—ADRA2A—type 2 diabetes mellitus	7.68e-05	0.0149	CrCbGaD
Propericiazine—Fluphenazine—CYP1A2—type 2 diabetes mellitus	7.48e-05	0.0146	CrCbGaD
Propericiazine—Promazine—HTR2C—type 2 diabetes mellitus	7.07e-05	0.0138	CrCbGaD
Propericiazine—Clomipramine—CYP1A2—type 2 diabetes mellitus	6.85e-05	0.0133	CrCbGaD
Propericiazine—Thioridazine—CYP2E1—type 2 diabetes mellitus	6.78e-05	0.0132	CrCbGaD
Propericiazine—Chlorpromazine—ADRA2A—type 2 diabetes mellitus	6.76e-05	0.0131	CrCbGaD
Propericiazine—Methotrimeprazine—CYP2E1—type 2 diabetes mellitus	6.47e-05	0.0126	CrCbGaD
Propericiazine—Thioridazine—CYP1A2—type 2 diabetes mellitus	6.45e-05	0.0125	CrCbGaD
Propericiazine—Chlorpromazine—HTR2C—type 2 diabetes mellitus	6.22e-05	0.0121	CrCbGaD
Propericiazine—Methotrimeprazine—CYP1A2—type 2 diabetes mellitus	6.16e-05	0.012	CrCbGaD
Propericiazine—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	5.98e-05	0.0116	CrCbGaD
Propericiazine—Perphenazine—CYP1A2—type 2 diabetes mellitus	5.92e-05	0.0115	CrCbGaD
Propericiazine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	5.73e-05	0.0112	CrCbGaD
Propericiazine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	5.48e-05	0.0107	CrCbGaD
Propericiazine—Promazine—CYP1A2—type 2 diabetes mellitus	5.34e-05	0.0104	CrCbGaD
Propericiazine—Acepromazine—ALB—type 2 diabetes mellitus	5.2e-05	0.0101	CrCbGaD
Propericiazine—Thioproperazine—ALB—type 2 diabetes mellitus	5.08e-05	0.00989	CrCbGaD
Propericiazine—Thiothixene—ALB—type 2 diabetes mellitus	5e-05	0.00973	CrCbGaD
Propericiazine—Pipotiazine—ALB—type 2 diabetes mellitus	5e-05	0.00973	CrCbGaD
Propericiazine—Chlorpromazine—CYP2E1—type 2 diabetes mellitus	4.94e-05	0.0096	CrCbGaD
Propericiazine—Chlorpromazine—CYP1A2—type 2 diabetes mellitus	4.7e-05	0.00913	CrCbGaD
Propericiazine—Clomipramine—CYP3A4—type 2 diabetes mellitus	4.53e-05	0.00881	CrCbGaD
Propericiazine—Clomipramine—ALB—type 2 diabetes mellitus	3.95e-05	0.00769	CrCbGaD
Propericiazine—Perphenazine—CYP3A4—type 2 diabetes mellitus	3.92e-05	0.00762	CrCbGaD
Propericiazine—Quetiapine—CYP3A4—type 2 diabetes mellitus	3.84e-05	0.00747	CrCbGaD
Propericiazine—Promazine—CYP3A4—type 2 diabetes mellitus	3.53e-05	0.00687	CrCbGaD
Propericiazine—Chlorpromazine—CYP3A4—type 2 diabetes mellitus	3.11e-05	0.00605	CrCbGaD
Propericiazine—Chlorpromazine—ALB—type 2 diabetes mellitus	2.71e-05	0.00527	CrCbGaD
Propericiazine—ADRA2A—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	1.75e-05	0.000277	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SPRY2—type 2 diabetes mellitus	1.75e-05	0.000277	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.75e-05	0.000277	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.75e-05	0.000277	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—GNB3—type 2 diabetes mellitus	1.72e-05	0.000273	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.72e-05	0.000273	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PIK3R1—type 2 diabetes mellitus	1.72e-05	0.000272	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—NOS3—type 2 diabetes mellitus	1.72e-05	0.000272	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.71e-05	0.000272	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—C3—type 2 diabetes mellitus	1.71e-05	0.000272	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.7e-05	0.00027	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.7e-05	0.00027	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.7e-05	0.00027	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MMP3—type 2 diabetes mellitus	1.7e-05	0.00027	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AVP—type 2 diabetes mellitus	1.7e-05	0.00027	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	1.69e-05	0.000268	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.68e-05	0.000266	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.65e-05	0.000263	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.65e-05	0.000262	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.65e-05	0.000262	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.63e-05	0.000259	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—SREBF1—type 2 diabetes mellitus	1.63e-05	0.000258	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PSMD6—type 2 diabetes mellitus	1.63e-05	0.000258	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—SNAP25—type 2 diabetes mellitus	1.63e-05	0.000258	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.63e-05	0.000258	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	1.62e-05	0.000257	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.61e-05	0.000255	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.6e-05	0.000255	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.6e-05	0.000255	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.6e-05	0.000254	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CTGF—type 2 diabetes mellitus	1.6e-05	0.000254	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.6e-05	0.000254	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	1.59e-05	0.000253	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—HMGCR—type 2 diabetes mellitus	1.58e-05	0.000251	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.57e-05	0.000249	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.56e-05	0.000248	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.56e-05	0.000248	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.55e-05	0.000247	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.54e-05	0.000245	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.53e-05	0.000244	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	1.53e-05	0.000243	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.52e-05	0.000241	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.52e-05	0.000241	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.51e-05	0.000239	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.51e-05	0.000239	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.5e-05	0.000238	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—INSR—type 2 diabetes mellitus	1.5e-05	0.000238	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP2E1—type 2 diabetes mellitus	1.49e-05	0.000236	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.48e-05	0.000236	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.48e-05	0.000236	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.48e-05	0.000235	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.48e-05	0.000234	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.47e-05	0.000234	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP1A2—type 2 diabetes mellitus	1.47e-05	0.000234	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—SLC2A1—type 2 diabetes mellitus	1.47e-05	0.000234	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.47e-05	0.000234	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.47e-05	0.000234	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.46e-05	0.000232	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.46e-05	0.000231	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.45e-05	0.000231	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.45e-05	0.00023	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.44e-05	0.000229	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP3A4—type 2 diabetes mellitus	1.44e-05	0.000228	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.44e-05	0.000228	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GCG—type 2 diabetes mellitus	1.43e-05	0.000227	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.43e-05	0.000227	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.43e-05	0.000227	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.41e-05	0.000224	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—C3—type 2 diabetes mellitus	1.41e-05	0.000224	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GCG—type 2 diabetes mellitus	1.41e-05	0.000224	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—SLC2A4—type 2 diabetes mellitus	1.41e-05	0.000224	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.41e-05	0.000223	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.4e-05	0.000223	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.4e-05	0.000223	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.37e-05	0.000218	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.36e-05	0.000217	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.36e-05	0.000216	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.36e-05	0.000216	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.34e-05	0.000213	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.34e-05	0.000213	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.34e-05	0.000212	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.32e-05	0.00021	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.32e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.32e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.31e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.31e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.29e-05	0.000205	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.29e-05	0.000205	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.29e-05	0.000204	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.27e-05	0.000202	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—SRC—type 2 diabetes mellitus	1.27e-05	0.000201	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.26e-05	0.0002	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.24e-05	0.000198	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.24e-05	0.000197	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—VEGFA—type 2 diabetes mellitus	1.24e-05	0.000196	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—C3—type 2 diabetes mellitus	1.23e-05	0.000196	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.23e-05	0.000196	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.22e-05	0.000193	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GNB3—type 2 diabetes mellitus	1.22e-05	0.000193	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AVP—type 2 diabetes mellitus	1.22e-05	0.000193	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.22e-05	0.000193	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—HMOX1—type 2 diabetes mellitus	1.21e-05	0.000192	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.21e-05	0.000192	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.21e-05	0.000191	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.2e-05	0.000191	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.2e-05	0.00019	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CAT—type 2 diabetes mellitus	1.19e-05	0.00019	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.19e-05	0.000189	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GCG—type 2 diabetes mellitus	1.18e-05	0.000187	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.18e-05	0.000187	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.18e-05	0.000187	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOB—type 2 diabetes mellitus	1.18e-05	0.000187	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.17e-05	0.000186	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.17e-05	0.000186	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.17e-05	0.000186	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.16e-05	0.000184	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOB—type 2 diabetes mellitus	1.16e-05	0.000184	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.16e-05	0.000184	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.16e-05	0.000184	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.15e-05	0.000183	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.15e-05	0.000182	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.15e-05	0.000182	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.14e-05	0.00018	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TGFB1—type 2 diabetes mellitus	1.13e-05	0.00018	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTM1—type 2 diabetes mellitus	1.13e-05	0.000179	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LPL—type 2 diabetes mellitus	1.12e-05	0.000178	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—LPL—type 2 diabetes mellitus	1.11e-05	0.000176	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.1e-05	0.000175	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.1e-05	0.000174	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.09e-05	0.000172	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ADCY5—type 2 diabetes mellitus	1.08e-05	0.000172	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.08e-05	0.000172	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.08e-05	0.000172	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GPX1—type 2 diabetes mellitus	1.08e-05	0.000172	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.05e-05	0.000167	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CD36—type 2 diabetes mellitus	1.05e-05	0.000167	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPP2CA—type 2 diabetes mellitus	1.04e-05	0.000165	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.03e-05	0.000164	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.03e-05	0.000163	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.02e-05	0.000163	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.02e-05	0.000161	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—C3—type 2 diabetes mellitus	1.01e-05	0.00016	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AVP—type 2 diabetes mellitus	1e-05	0.000159	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	1e-05	0.000159	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.99e-06	0.000159	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MTHFR—type 2 diabetes mellitus	9.97e-06	0.000158	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.95e-06	0.000158	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.85e-06	0.000156	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—INS—type 2 diabetes mellitus	9.81e-06	0.000156	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPARA—type 2 diabetes mellitus	9.78e-06	0.000155	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOB—type 2 diabetes mellitus	9.7e-06	0.000154	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.66e-06	0.000153	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.66e-06	0.000153	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.64e-06	0.000153	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.61e-06	0.000153	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AGT—type 2 diabetes mellitus	9.6e-06	0.000152	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.55e-06	0.000152	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.49e-06	0.000151	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.49e-06	0.000151	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AGT—type 2 diabetes mellitus	9.48e-06	0.00015	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.45e-06	0.00015	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.44e-06	0.00015	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LEP—type 2 diabetes mellitus	9.41e-06	0.000149	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOE—type 2 diabetes mellitus	9.41e-06	0.000149	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CALM1—type 2 diabetes mellitus	9.32e-06	0.000148	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.3e-06	0.000148	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOE—type 2 diabetes mellitus	9.28e-06	0.000147	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LPL—type 2 diabetes mellitus	9.26e-06	0.000147	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOA1—type 2 diabetes mellitus	9.18e-06	0.000146	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.07e-06	0.000144	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.01e-06	0.000143	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.87e-06	0.000141	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.69e-06	0.000138	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.61e-06	0.000137	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.61e-06	0.000137	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.53e-06	0.000135	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.39e-06	0.000133	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—C3—type 2 diabetes mellitus	8.34e-06	0.000132	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	8.1e-06	0.000129	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	8.09e-06	0.000128	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—INS—type 2 diabetes mellitus	8.04e-06	0.000128	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.95e-06	0.000126	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.93e-06	0.000126	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	7.93e-06	0.000126	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	7.92e-06	0.000126	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.91e-06	0.000126	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	7.89e-06	0.000125	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.79e-06	0.000124	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.77e-06	0.000123	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.77e-06	0.000123	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	7.76e-06	0.000123	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	7.76e-06	0.000123	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.73e-06	0.000123	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.67e-06	0.000122	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.38e-06	0.000117	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.37e-06	0.000117	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.32e-06	0.000116	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.31e-06	0.000116	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	7.27e-06	0.000115	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.26e-06	0.000115	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.05e-06	0.000112	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.05e-06	0.000112	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	6.96e-06	0.00011	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	6.96e-06	0.00011	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.93e-06	0.00011	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.9e-06	0.00011	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.83e-06	0.000108	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.7e-06	0.000106	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	6.63e-06	0.000105	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	6.63e-06	0.000105	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.53e-06	0.000104	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.42e-06	0.000102	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.41e-06	0.000102	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.38e-06	0.000101	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	6.37e-06	0.000101	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	6.36e-06	0.000101	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.2e-06	9.84e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.09e-06	9.67e-05	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.04e-06	9.59e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.98e-06	9.5e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.94e-06	9.44e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.82e-06	9.23e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.82e-06	9.23e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.69e-06	9.03e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.65e-06	8.98e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.59e-06	8.88e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.58e-06	8.86e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.48e-06	8.71e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.47e-06	8.69e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	5.21e-06	8.28e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.08e-06	8.06e-05	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.98e-06	7.91e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.94e-06	7.84e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.91e-06	7.79e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.67e-06	7.41e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.66e-06	7.4e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.62e-06	7.33e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.57e-06	7.25e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.53e-06	7.18e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.3e-06	6.83e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.29e-06	6.81e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.19e-06	6.65e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.96e-06	6.28e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.85e-06	6.11e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.77e-06	5.99e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	3.51e-06	5.57e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.24e-06	5.14e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	3.2e-06	5.08e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.9e-06	4.6e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.67e-06	4.24e-05	CbGpPWpGaD
